Beneficient (BENF) Payout Ratio (2022 - 2023)
Beneficient's (BENF) quarterly Payout Ratio came in at 0.0 in Q4 2023, up 77.6% quarter-over-quarter from 0.0 in Q3 2022.
Powered by 
Analysis
Beneficient (BENF) Payout Ratio (2022 - 2023) Analysis & Trends
Beneficient has disclosed Payout Ratio across 2 years of filings, most recently posting 0.0 for Q4 2023.
- In Q4 2023, Payout Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2025 stood at 0.01 (up 4196.09% YoY), while the FY2024 annual figure was 0.0, up 87.17% from the prior year.
- Payout Ratio came in at 0.0 for Q4 2023 at Beneficient, up from 0.0 in the prior quarter.
- In the past five years, Payout Ratio ranged from a high of 0.0 in Q4 2023 to a low of 0.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 43.61 Bn | 43.61 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 26.50 Bn | 25.66 Bn | - |
| 3 | Royal Gold | 21.74 Bn | 21.56 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.80 Bn | 6.72 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.10 Bn | 1.91 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.40 Bn | 839.95 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Upbound | 1.07 Bn | 964.32 Mn | 594.84 Mn |
| 9 | Lufax Holding | 1.05 Bn | -1.58 Bn | - |
| 10 | Beneficient | 2.67 Mn | -2.93 Mn | - |